Vadadustat is an orally administered small molecule that inhibits hypoxia-inducible factor prolyl-hydroxylase (HIF-PH), thereby mimicking hypoxic conditions to stimulate erythropoiesis. It is used as an active pharmaceutical ingredient in the management of anemia associated with chronic kidney disease in adults on maintenance dialysis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1000025-07-9
Cis-Etoposide
pharmaceutical raw material
Sulopenem etzadroxil
pharmaceutical raw material
Tegobuvir
pharmaceutical raw material
ARQ 197
pharmaceutical raw material
3-phenylpyridine
research compound
2-(pyridin-3-yl)benzoic acid
research compound
2-(Pyridin-3-yl)-5-(trifluoromethyl)benzenamine
Research reagent
4-(Pyridin-3-yl)phenylboronic acid
research compound
2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
JGRXMPYUTJLTKT-UHFFFAOYSA-N
C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O